# NEWSLETTER: GLP-1 drugs help control prediabetes better than current standard medicine

> **Open Intelligence Dossier** · First detected: 2026-11-05 03:00 UTC · Category: Health

## Executive Summary
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"NEWSLETTER: GLP-1 drugs help control prediabetes better than current standard medicine" is generating significant coverage in the Health category, with 7 articles from 7 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Medical Daily, U.S. News & World Report, MDLinx and Newsweek. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Medical Daily | GLP-1 Drugs Tied to 31% Lower Diabetes Risk Than Metformin in 256,492 Adults With Prediabetes and Obesity | [Source Link](https://news.google.com/rss/articles/CBMiigFBVV95cUxNUlprOEdnaUFnZmFlcVhQTGVaQWIyQ3h0OWJweERTLXE3S1RqUEQzMXlPVHd0QktsRV9QRG5WaW4xeFJvM3R0bWxhbzVJRjZvUTNSdVBfVDVHQ2V2NmxSZldEcHdOMjhiUlozcUVSSnhxS3NJVjBSWEE4QWVtejRmSjNCcl96MXEtZUE?oc=5) |
| U.S. News & World Report | GLP-1 Drugs Can Help Reverse Prediabetes, Researchers Report | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxNS1dzSnBBYXFNYmNvNnNzZXZXaXBzU29Ib2dHbjZyT0ZIZ2NzbTFSS1RoTmpYMUx0UGdVaGNZcTNZTlhTVnJqVnRXNExkdUxEeVpiU2s2bXRTSDA1Znd2UjIwUW1DY2ZTaVhkNlBNajY0TU40YVg2SlctaU1IcnFyM1dCT1NRVFF2ZEswbGNwYUZXTUdoR2hJX2FKMWstUVh1NTA3M0szVzlwOGFsdy1pMTNJUWFzS0l3VlAw?oc=5) |
| MDLinx | GLP-1s vs metformin: Could earlier treatment change the course of prediabetes? | [Source Link](https://news.google.com/rss/articles/CBMiygFBVV95cUxOU0l2WHdWd0pTZDlEZUV3cUM4MkpMdnY4cDlUSFdHUmg4QWVtTHFDZU5TQ3J4WWQ1cGNhbXlnRmlHTU9qeGE5VlFtZEFhTnh6TTlWbG9qNUpzcXdQZXpsLTA3aFc5a2pVUk9MLUxLbHBTb3UwdHV4XzAyTzNlOTZJQ2lwUXZfUk9ZNkZuYTRrbnNhQVFqRm11QjFhUUt2UFNFWko2RThySmNaZmxDbk1sdThmZDVMVDRsdUk1cUllZGg1cXNzUkpvSHhn?oc=5) |
| Newsweek | GLP-1 Users Saw Lower Risks of Heart Attack and Stroke in Major Study | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxOWmtiOXNDbWdxMXF2Y25nTTRtX3dZb2hwQzAzTk9aV1dFdG5vOUwxUEhHY1VjMUpyTU1RYjBpMlBNVVVXcWtDN1IyY1pWNlFDdDBjeGI0Z0x5OTU1aFhaSkdqZ2FTTmJnX3h4T2hkVW9OMDlXV0hCVWp2dmc4M2ZyY2VXR0NPWlVnQThXcm14N3dFZmRha2pJSA?oc=5) |
| The Times of India | ‘Diabetes patients tend to lose less weight with GLP-1 drugs than others’ | [Source Link](https://news.google.com/rss/articles/CBMi1wFBVV95cUxQV2d2ejAxaTlpZUFBQXBHVDZiSl9rSExnOER6bHUwbmQ2endCbVF2dTA0dHRoa0xrbFJyWXkxRTAtLWNzZlVzbXBSZlAyUTA2Uk5HTGZOMTNRejlXSFVqcmVieDZCTEo3ek5lMWQ5b3VFdjBsRl9CNEtIeDlEWUtwdlMzVXAwd3JVN3V3LU1sXzdDeDBxanAtRlItcFlOZFI1Um5SUDM4YkFRRDJ0dkh4RGVLV2pzOWp3WkpBdl9UdFUtQUotZXhac09JQS1nOGtzM3BOSW1DVQ?oc=5) |
| Gazeta Express | Study: Ozempic and Mounjaro may be more effective than metformin in preventing type 2 diabetes | [Source Link](https://news.google.com/rss/articles/CBMizwFBVV95cUxOQVZreVpfZjZPWnlzSVY2WUhFeFJaal9XN0hweEFqbmoxRzRxODlRc3dmQ2xFOVNTVWl4c0ttOURqN3lMUDRBbUdiZnE3aUtHYm5vZzNfRGwyR3psTXFXaUlfN2tLSkJXdEdDUFdBQlBNcWxwakljTk5UcGN3bHRfZWU5VkdVZkRmZnRIaXV2dUk2V2xBaU1lTS0xVmJrcHJkZlpqSmtjV0pnTHJKdVYxOC1JeGdVSVlPR2hvRXNuVVVtQTRkMW84U0tRcTlrWXM?oc=5) |
| Reuters | NEWSLETTER: GLP-1 drugs help control prediabetes better than current standard medicine | [Source Link](https://news.google.com/rss/articles/CBMi3wFBVV95cUxORHJraGhpZDJuNGN4MGhLWkR2UEltdXpUaVphcjVHVGU1WERiSElLc1d1UUE4blNsUDR5ZmRZcVFoVFE1RkhCMnhXWUt3WndiQzQ3LWh4aXBibWV6dXlXb0Nkd0RleHpvdmNnSWc1a0prQnR4MDI1QXFzZEdfSW02UFdxTGxNZ1A4SmYyakd4Vml2NDlHbjdtWko3NV80Y2hTVDlNUnAwSkZYYkhqczlNczA3VHVxcUJURXFEYjJhRnhMWGRCZFgzc0NrcVJZYjRWSnEzSDRmMmk2UktLeS0w?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-11-05/newsletter-glp-1-drugs-help-control-prediabetes-better-than-current-standard*